Anna Galperin is the UW Center for Dialysis Innovation Director of Research and Development. She received her MSc in Medicinal Organic Chemistry in 2000 and graduated with a PhD in Polymer Chemistry in 2006 from Bar-Ilan University, Israel, where she was awarded the “Eshkol Fellowship for Outstanding Graduate Student” from the Israeli Ministry of Science and Technology. In 2008, Dr. Galperin moved to Seattle to complete her postdoctoral research in the Department of Bioengineering at the University of Washington, under the guidance of Professor Buddy Ratner. Upon completion in 2013, Dr. Galperin continued to pursue her career in industry. She is the author of 16 peer-reviewed publications and co-author of several patents and book chapters. Dr. Galperin possesses a uniquely multidisciplinary experience that spans fields such as polymer chemistry, medicinal and analytical chemistry as well as bioengineering. She developed her diverse expertise through a successful career in academia and industry; in both settings her work combined drug-delivery platforms for imaging, tissue engineering, and the development of new treatments for Alzheimer’s disease and genetic disorders. Dr. Galperin holds a Certificate in Biotechnology Project Management and a Certificate in Biomedical Regulatory Affairs from the University of Washington.
Director of Research & Development, Center for Dialysis Innovation, University of Washington
Former Scientist, PhaseRx